Multidrug Resistance Studies in Acute Myeloid Leukemia

Trial Profile

Multidrug Resistance Studies in Acute Myeloid Leukemia

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 10 Aug 2017

At a glance

  • Drugs Valspodar (Primary) ; Antineoplastics
  • Indications Acute myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by
    • 10 Jan 2011 Planned number of patients changed from 250 to 2034 as reported by
    • 09 Nov 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top